Skip to Content


New Sister in Hong Kong

Conquest - Fall 2008

M. D. Anderson and the Sir Y.K. Pao Centre for Cancer and Hong Kong Cancer Institute at the Chinese University of Hong Kong have signed a sister institution agreement that formalizes existing collaboration in research and patient care and expands the scope of our joint efforts.

Anthony T.C. Chan, M.D., director of the Cancer Center at the Chinese University of Hong Kong; Karen Fields, M.D., vice president for global academic programs at M. D. Anderson; and Tai Fai Fok, M.D., dean, faculty of medicine, Chinese University of Hong Kong, sign a formal agreement between the two institutions at a press conference.

“The Chinese University of Hong Kong has renowned clinical and academic research programs and remarkable therapeutic expertise,” says John Mendelsohn, M.D., president of M. D. Anderson. “The new partnership will create and support more opportunities for innovative cancer research collaborations to ultimately reduce the incidence of cancer and suffering among patients globally.”

Cancer is the number one cause of death in China. In 2005, approximately 1,892,000 people died from cancer and the number of new cases is increasing at a rapid rate.

The institutions have identified nasopharyngeal carcinoma, hepatocellular carcinoma and glioma as initial research areas of focus. The collaboration aims to establish a clinical trial network among China, East Asia and M. D. Anderson, and educational exchange programs for post-graduate students, clinical fellows and oncology nurses with training opportunities at CUHK.

To date, M. D. Anderson has established sister institution relationships with 18 premier academic and clinical cancer centers around the world.

© 2015 The University of Texas MD Anderson Cancer Center